Aclarion

Aclarion EBITDA per Share

The EBITDA per Share of Aclarion (ACON) as of Oct 16, 2026 is -13.26 USD. In the previous year, EBITDA per Share was -4,612.47 USD — a change of -99.71% (higher).

EBITDA per Share

-13.26USD

YoY

-99.71%

Last updated:

EBITDA per Share of Aclarion is 2025 -13.26 USD. EBITDA per Share of Aclarion was 2024 -4,612.47 USD. It decreases by -99.71% higher compared to the previous year.

The Aclarion EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-1.63 USD
Jan 1, 2022
-55,635.57 USD
Jan 1, 2023
-43,032.58 USD
Jan 1, 2024
-4,612.47 USD
Jan 1, 2025
-13.26 USD
The Aclarion EBITDA per Share history
YEAREBITDA per ShareYoY
-13.26USD-99.71%
-4,612.47USD-89.28%
-43,032.58USD-22.65%
-55,635.57USD+3.41 M%
-1.63USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aclarion Stock analysis

What does Aclarion do? Aclarion Inc, trading under the ticker ACON, is a healthcare technology company based in Broomfield, Colorado, with a focus on medical diagnostics. The company specializes in Magnetic Resonance Spectroscopy (MRS) and has developed a proprietary biomarker designed to optimize clinical treatments for patients with chronic low back pain. Aclarion's technology processes raw MRS data using signal processing software and an expert system to generate clear metabolic biomarkers. These biomarkers help physicians distinguish between painful and nonpainful lumbar discs. The company utilizes augmented intelligence in a post-processing algorithm to analyze and quantify biomarker data, producing individualized ratio metrics for each lumbar disc based on a normative data set. Aclarion went public via an IPO on April 22, 2022. The company employs seven full-time staff members. Its website is aclarion.com. Aclarion operates within the Health Care sector and Industry, targeting the optimization of treatment strategies for chronic low back pain through advanced diagnostic tools. Aclarion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aclarion stock

EBITDA per Share of Aclarion is -13.26 USD in 2025.

EBITDA per Share of Aclarion changed from -4,612.47 USD to -13.26 USD, representing a -99.71% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Aclarion since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Aclarion

All Key Metrics — Aclarion